Skip to content
value.today

OptiNose, Inc.

🇺🇸 New York, New York, USAHealth CareFounded 2010
Total raised
$99 M
6 rounds on record
Latest round
$5 M
May 2024
First round on record
Jul 2014
Today
Private
No later event on record

Funding rounds

6 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of OptiNose, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2024$5 MNo. 6$2 to $10 million

OptiNose, Inc.: Raise no. 6, May 2024

Investors in this round

2 investors had bought by the notice of May 20, 2024: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 12 investors are named for OptiNose, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anthony J. Krick · Executive Officer · Chief Accounting Officer
  • Michael F. Marino · Executive Officer · Chief Legal Officer and Corporate Secretary
  • Paul A. Spence · Executive Officer · Chief Commercial Officer
  • Ramy A. Mahmoud · Director, Executive Officer · Chief Executive Officer
  • Catherine E. Owen · Director
  • Eric John Bednarski · Director
  • Kyle John Dempsey · Director
  • R. John Fletcher · Director
  • Sandra L. Helton · Director
  • Tomas J. Heyman · Director
  • Wilhelmus John Groenhuysen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael F. Marino, Chief Legal Officer and Corporate Secretary. Source: SEC Form D, newest notice filed May 20, 2024. Read the notice at the SEC.

equitySEC
Nov 2021$4 MNo. 5$2 to $10 million

OptiNose, Inc.: Raise no. 5, Nov 2021

Investors in this round

2 investors had bought by the notice of Nov 30, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 12 investors are named for OptiNose, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Keith A. Goldan · Executive Officer · Chief Financial Officer
  • Michael F. Marino · Executive Officer · Chief Legal Officer and Corporate Secretary
  • Peter K. Miller · Executive Officer, Director · Chief Executive Officer
  • Ramy A. Mahmoud · Executive Officer · President and Chief Operating Officer
  • Victor M. Clavelli · Executive Officer · Chief Commercial Officer
  • Catherine E. Owen · Director
  • Joseph C. Scodari · Director · Chairman of Board of Directors
  • Sandra L. Helton · Director
  • Tomas J. Heyman · Director
  • Wilhelmus C. Groenhuysen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael F. Marino, Chief Legal Officer and Corporate Secretary. Source: SEC Form D, newest notice filed Nov 30, 2021. Read the notice at the SEC.

equity, optionsSEC
Sep 2019$5 MNo. 4$2 to $10 million

OptiNose, Inc.: Raise no. 4, Sep 2019

Investors in this round

2 investors had bought by the notice of Sep 25, 2019: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 12 investors are named for OptiNose, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Keith A. Goldan · Executive Officer · Chief Financial Officer
  • Michael F. Marino · Executive Officer · Chief Legal Officer and Corporate Secretary
  • Peter K. Miller · Executive Officer, Director · Chief Executive Officer
  • Ramy A. Mahmoud · Executive Officer · President and Chief Operating Officer
  • Joseph C. Scodari · Director · Chairman of Board of Directors
  • Joshua A. Tamaroff · Director
  • Robert P. O'Neil · Director
  • Sandra L. Helton · Director
  • Sriram A. Venkataraman · Director
  • Wilhelmus F. Groenhuysen · Director
  • William F. Doyle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael F. Marino, Chief Legal Officer and Corporate Secretary. Source: SEC Form D, newest notice filed Sep 25, 2019. Read the notice at the SEC.

equity, optionsSEC
Mar 2017$35 MNo. 3$10 to $50 million

OptiNose, Inc.: Raise no. 3, Mar 2017

Investors in this round

8 investors had bought by the notice of Apr 7, 2017: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 12 investors are named for OptiNose, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Keith Goldan · Executive Officer
  • Michael F. Marino · Executive Officer
  • Peter Miller · Executive Officer, Director
  • Ramy Mahmoud · Executive Officer
  • Tom F. Gibbs · Executive Officer
  • Joshua Tamaroff · Director
  • Klaas De Boer · Director
  • Larry Pickering · Director
  • Patrick F. O'Neill · Director
  • Per Djupesland · Director
  • Sriram Venkataraman · Director
  • William F. Doyle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Marino, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 7, 2017. Read the notice at the SEC.

equity, optionsSEC
Sep 2015$15 MNo. 2$10 to $50 million

OptiNose, Inc.: Raise no. 2, Sep 2015

Investors in this round

21 investors had bought by the notice of Oct 13, 2015: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 12 investors are named for OptiNose, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$15 M of $30 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michele F. Janis · Executive Officer
  • Per Djupesland · Executive Officer, Director
  • Peter Miller · Director, Executive Officer
  • Ramy F. Mahmoud · Executive Officer
  • Terrence F. Terifay · Executive Officer
  • Jackson F. Phillips · Director
  • Klaas De Boer · Director
  • Larry F. Pickering · Director
  • Patrick F. O'Neill · Director
  • Sriram F. Venkataraman · Director
  • William F. Doyle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michele Janis, Treasurer. Source: SEC Form D, newest notice filed Oct 13, 2015. Read the notice at the SEC.

equity, debt, optionsSEC
Jul 2014$35 MNo. 1$10 to $50 million

OptiNose, Inc.: Raise no. 1, Jul 2014

Investors in this round

23 investors had bought by the notice of Oct 13, 2015: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 12 investors are named for OptiNose, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michele F Janis · Executive Officer
  • Per Djupesland · Executive Officer, Director
  • Peter Miller · Executive Officer, Director
  • Ramy F Mahmoud · Executive Officer
  • Terrence F Terifay · Executive Officer
  • Jackson F Phillips · Director
  • Klaas De Boer · Director
  • Larry F Pickering · Director
  • Patrick F O'Neill · Director
  • Sriram F Venkataraman · Director
  • William F Doyle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michele Janis, Treasurer. Source: SEC Form D and 1 amendment, newest notice filed Oct 13, 2015. Read the notice at the SEC.

equity, optionsSEC
Jun 2010$21 MIssued in a merger or acquisition$10 to $50 million

OptiNose, Inc.: Private sale, Jun 2010

Investors in this round

23 investors had bought by the notice of Jun 21, 2010: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 12 investors are named for OptiNose, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$21 M of $49 M offered; $28 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock; Series A, B-1, B-2 and C Preferred Stock; Common Stock Warrants
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Helena Kyttari Djupesland · Executive Officer
  • Henrik Bruun Andersen · Executive Officer
  • Peter Miller · Executive Officer
  • Ramy Kyttari Mahmoud · Executive Officer
  • Klaas Bruun de Boer · Director
  • Larry F. Pickering · Director
  • Patrick F. O'Neill · Director
  • Per Bruun Djupesland · Director
  • Sriram F. Venkataraman · Director
  • William F. Doyle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This amount does not include the FMV of the securities issued in the exchange.”
  • On a merger: “A private offering of Series C Preferred Stock and Common Stock is being made in connection with, and subsequent to, a security-for-security exchange in the formation of the issuer.”

Signed by Peter Miller, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 21, 2010. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • OptiNose, Inc. chose not to state its revenue in its newest notice of a funding round (May 2024).

    SEC Form D · May 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · May 2024

That is all the official record says: OptiNose, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

12 named in official filings. Open an investor to see everything it has backed.

Investors in OptiNose, Inc.
InvestorKindAmountRoundRoleSource
Avista Capital Partners II GP, LLCFund or asset managernot statednot statedHeld Series C, C-1, C-2 and D preferred stock, 10% owner (Form 3, 2017)SEC Form 3
Avista Capital Partners II, L.P.Fund or asset managernot statednot statedHeld Series C, C-1, C-2 and D preferred stock, 10% owner (Form 3, 2017)SEC Form 3
Avista Capital Partners (Offshore) II-A, LPFund or asset managernot statednot statedHeld Series C, C-1, C-2 and D preferred stock, 10% owner (Form 3, 2017)SEC Form 3
Avista Capital Partners (Offshore) II, L.P.Fund or asset managernot statednot statedHeld Series C, C-1, C-2 and D preferred stock, 10% owner (Form 3, 2017)SEC Form 3
Entrepreneurs Fund General Partner LtdFund or asset managernot statednot statedHeld Series A, B-1, C, C-1, C-2 and D preferred stock, 10% owner (Form 3, 2017)SEC Form 3
Entrepreneurs Fund LPFund or asset managernot statednot statedHeld Series A, B-1, C, C-1, C-2 and D preferred stock, 10% owner (Form 3, 2017)SEC Form 3
Larry G. PickeringPersonnot statednot statedHeld Series C, C-1 and C-2 preferred stock, director (Form 3, 2017)SEC Form 3
Peter K. MillerPersonnot statednot statedHeld Series C, C-1 and C-2 preferred stock, director (Form 3, 2017)SEC Form 3
Ramy A. MahmoudPersonnot statednot statedHeld Series C-1 and C-2 preferred stock (Form 3, 2017)SEC Form 3
TKWD Ventures LLCVenture capitalnot statednot statedHeld Series B-2, C, C-1 and C-2 preferred stock, 10% owner (Form 3, 2017)SEC Form 3
WFD Ventures LLCVenture capitalnot statednot statedHeld Series B-2, C, C-1 and C-2 preferred stock, 10% owner (Form 3, 2017)SEC Form 3
William F. DoylePersonnot statednot statedHeld Series B-2, C-1, C-2 and D preferred (Form 3, 2017)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 23 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by OptiNose, Inc.
NameRoleNamed in
Anthony J. KrickChief Accounting OfficerMay 2024
Michael F. MarinoChief Legal Officer and Corporate SecretaryMay 2024
Paul A. SpenceChief Commercial OfficerMay 2024
Ramy A. MahmoudChief Executive OfficerMay 2024
Keith A. GoldanChief Financial OfficerNov 2021
Peter K. MillerChief Executive OfficerNov 2021
Victor M. ClavelliChief Commercial OfficerNov 2021
Keith GoldanExecutive officerApr 2017
Peter MillerExecutive officerApr 2017
Ramy MahmoudExecutive officerApr 2017
Tom F. GibbsExecutive officerApr 2017
Michele F JanisExecutive officerOct 2015
Michele F. JanisExecutive officerOct 2015
Per DjupeslandExecutive officerOct 2015
Ramy F MahmoudExecutive officerOct 2015
Ramy F. MahmoudExecutive officerOct 2015
Terrence F TerifayExecutive officerOct 2015
Terrence F. TerifayExecutive officerOct 2015
Helena Kyttari DjupeslandExecutive officerJun 2010
Henrik Bruun AndersenExecutive officerJun 2010
Ramy Kyttari MahmoudExecutive officerJun 2010
Catherine E. OwenDirectorMay 2024
Eric John BednarskiDirectorMay 2024
Kyle John DempseyDirectorMay 2024
R. John FletcherDirectorMay 2024
Ramy A. MahmoudChief Executive OfficerMay 2024
Sandra L. HeltonDirectorMay 2024
Tomas J. HeymanDirectorMay 2024
Wilhelmus John GroenhuysenDirectorMay 2024
Joseph C. ScodariChairman of Board of DirectorsNov 2021
Peter K. MillerChief Executive OfficerNov 2021
Wilhelmus C. GroenhuysenDirectorNov 2021
Joshua A. TamaroffDirectorSep 2019
Robert P. O'NeilDirectorSep 2019
Sriram A. VenkataramanDirectorSep 2019
Wilhelmus F. GroenhuysenDirectorSep 2019
William F. DoyleDirectorSep 2019
Joshua TamaroffDirectorApr 2017
Klaas De BoerDirectorApr 2017
Larry PickeringDirectorApr 2017